Clinical Trials Browser

Head and Neck Neoplasms

NCT04823468 2025-06-10

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

Phase NA Completed

236 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Body Weight

NCT02072148 2024-05-06

The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)

Phase NA Completed

112 enrolled 11 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00502463 2024-02-07

ASOG-HNO1

Phase NA Completed

51 enrolled

Head & Neck

Head and Neck Neoplasms

NCT05717790 2023-02-08

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Phase NA Recruiting

288 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05352321 2022-07-01

Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma

Phase NA Recruiting

264 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02289807 2021-10-15

Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy

Phase NA Withdrawn

Head & Neck

Nasopharyngeal Carcinoma

NCT02177838 2021-04-21

Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer

Phase NA Terminated

8 enrolled 9 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

NCT03981068 2020-09-25

DAHANCA 37. Re-irradiation With Proton Radiotherapy

Phase NA Unknown

20 enrolled

Head & Neck

Head and Neck Neoplasms, Recurrence

NCT02627807 2020-06-16

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Phase NA Unknown

386 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT00580983 2016-09-07

Optimized Intensity Modulated Irradiation for Head and Neck Cancer

Phase NA Completed

90 enrolled 11 charts

Head & Neck

Head and Neck Neoplasms

NCT01790516 2014-10-02

Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer

Phase NA Terminated

2 enrolled 7 charts

Head & Neck

Head and Neck Neoplasms

NCT00563862 2011-06-16

Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)

Phase NA Terminated

465 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Carcinoma, Squamous Cell, Nasopharyngeal Neoplasms

NCT00563927 2010-07-07

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

Phase NA Unknown

340 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Carcinoma, Squamous Cell, Nasopharyngeal Neoplasms

Clinical Trials

Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)

ASOG-HNO1

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma

Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy

Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer

DAHANCA 37. Re-irradiation With Proton Radiotherapy

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Optimized Intensity Modulated Irradiation for Head and Neck Cancer

Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer

Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)